Trading advice is based on information taken from trade and statistical services and other sources Blue Line Futures, LLC believes are reliable. We do not guarantee that such information is accurate ...
Below is a look at historical price averages for April futures on a 5, 10, 15, 20, and 30 year time frames (Past performance ...
William Blair analyst A. Brackmann anticipates that the medical instruments supplier will post earnings of $3.34 per share for […] ...
Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...
Shares of Becton, Dickinson and Company (NYSE:BDX – Get Free Report) have earned an average rating of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat.com reports ...
Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...
In November, the company announced that it had decided to discontinue its insulin patch pump program and would initiate ... Price Action: BDX stock is down 3.88% at $235.56 at the last check ...
Becton, Dickinson and Company announced it repurchased $750M in BD stock to date in FY25. In addition, the board has authorized the company to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback